NIH PAR · NIAID · P30

PAR-28-090: Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Opens Apr 25, 2027Next due date: May 25, 2027Expires May 26, 2029

The purpose of this notice of funding opportunity (NOFO) is to invite applications for the Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) programs to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide infrastructure, expertise, resources, and services not readily obtained through other funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-28-090
Type
PAR
Activity code
P30
Primary institute
NIAID · National Institute of Allergy and Infectious Diseases
Clinical trials
Not Allowed
Posted
Oct 16, 2026
Opens
Apr 25, 2027
Expires
May 26, 2029

PAR-28-090 due dates

3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-28-090
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
May 25, 2027 *May 25, 2027 *Not ApplicableNovember 2027January 2028March 2028
May 25, 2028 *May 25, 2028 *Not ApplicableNovember 2028January 2029March 2029
May 25, 2029 *May 25, 2029 *Not ApplicableNovember 2029January 2030March 2030

What its predecessor PAR-23-116 funded

PAR-28-090 reissues PAR-23-116. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 10 projects and $51.2M in FY2022–FY2026.

Projects funded

10

Distinct projects, FY2022–FY2026

New awards

2

Type 1 (new project) award records

NIH funding

$51.2M

Award dollars under PAR-23-116, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-23-116
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY202450$9.0M
FY202580$17.8M
FY2026112$24.4M

Institutions with the most funding

  1. Harvard University$11.7M · 1 project
  2. University of Pennsylvania$8.8M · 1 project
  3. University of Alabama at Birmingham$6.1M · 1 project
  4. Duke University$5.8M · 1 project
  5. Northwestern University$5.0M · 1 project
  6. Vanderbilt University Medical Center$3.5M · 1 project
  7. Univ of North Carolina Chapel Hill$3.2M · 1 project
  8. George Washington University$2.9M · 1 project

Funding institutes

  • NIAID$51.2M · 24

Activity codes funded

Most recent new awards

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

13 NIH institutes and offices take applications under PAR-28-090. Contact the program officer at the institute that fits your research before applying.

  • NIAID · National Institute of Allergy and Infectious Diseases
  • OAR
  • NHLBI · National Heart, Lung, and Blood Institute
  • NIA · National Institute on Aging
  • NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • NIDCR · National Institute of Dental and Craniofacial Research
  • NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
  • NIDA · National Institute on Drug Abuse
  • NIMH · National Institute of Mental Health
  • NINR · National Institute of Nursing Research
  • NIMHD · National Institute on Minority Health and Health Disparities
  • FIC · Fogarty International Center
  • NCI · National Cancer Institute

Related notices

  1. Jan 23, 2026 · NOT-OD-26-031

    NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research.

Award terms

Application types allowed
New Renewal - Renewal applications can only be submitted for awards funded through PAR-23-116 and their prior issuance. Resubmission The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Application budgets are not limited but need to reflect the actual needs of the proposed project and are dependent on the applicant institutions' NIH HIV/AIDS-funded research base FRB) and whether the application is for a CFAR or a D-CFAR. See
Project period
The scope of the proposed project should determine the project period. The maximum project period is five years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

Related NOFOs

  • Reissue of PAR-23-116.

Other open NOFOs for P30

Browse all open NIH NOFOs

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO

NIH grant searchLook up awards by topic, PI, or institution.Find funded PIsInvestigators with recent NIH awards in your research area.Institute fit by topicWhich NIH institutes and institutions lead a research area.Funding trendsYear-by-year NIH award totals for any keyword.